SUBSCRIBE
SUBSCRIBE
News   Business

Novartis Corporation to Build $700 Million Biotech Plant in Singapore

October 29, 2007 | 
1 min read

SINGAPORE, Oct 29 (Reuters) - Swiss pharmaceuticals group Novartis AG (NOVN.VX: Quote, Profile, Research) said on Monday it will build a $700 million cell culture plant in Singapore to support its growing biopharmaceutical business.

Real estate Asia
MORE ON THIS TOPIC
Pictured: AstraZeneca building in Gothenburg/iStoc
China
AstraZeneca Names New International Operations Lead Amid Probe on China Exec
December 5, 2024
 · 
3 min read
 · 
Tristan Manalac
Funding
Nuvig Ropes in $161M Series B From Big Pharma Players for Autoimmune Indications
December 5, 2024
 · 
1 min read
 · 
Kate Goodwin
Handshake gesture contemporary collage art. Celebrating success, congratulating for financial and business partnership, job contract deal, mutual friendship and respect. Abstract illustration isolated.
Alzheimer’s disease
GSK Strikes Third Agreement This Week, Leans Further Into Neuro
December 5, 2024
 · 
2 min read
 · 
Tristan Manalac
Facade of Novo Nordisk's office in Fremont, California
Manufacturing
Novo Continues Manufacturing Spending Spree With $400M Denmark Expansion, $200M Plant Purchase
December 5, 2024
 · 
2 min read
 · 
Tristan Manalac